Thinking in Speech for Children With Autism
1 other identifier
interventional
22
1 country
1
Brief Summary
This study examines a cognitive therapy for autistic children, Thinking in Speech. Thinking in Speech helps children with autism independently cope with everyday events that cause stress, by developing their ability to use "inner speech".
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 12, 2021
CompletedFirst Submitted
Initial submission to the registry
February 15, 2022
CompletedFirst Posted
Study publicly available on registry
February 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 10, 2022
CompletedOctober 3, 2024
October 1, 2024
1.2 years
February 15, 2022
October 1, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change from Baseline in Emotion Dysregulation Inventory scores to Post-Intervention
This measure assesses participants' emotion dysregulation via a 30-item measure. 24 items measure reactivity and 6 items measure dysphoria. A raw score is created by summing the items for each subscale, and ranges from 0-96. Higher scores indicate greater emotion dysregulation and lower scores indicate less emotional dysregulation. Participants will be assessed using this measure at baseline and after therapy is completed.
Up to 20 weeks
Secondary Outcomes (3)
Number of Thinking in Speech therapy sessions attended among all participants
Up to 20 weeks
Change from Baseline in Patient-Reported Outcomes Measurement Information System - Anger Measure to Post-Intervention
Up to 20 weeks
Change from Baseline in Patient-Reported Outcomes Measurement Information System - Anxiety Short Form to Post-Intervention
Up to 20 weeks
Study Arms (2)
Immediate Assignment to Intervention Group
EXPERIMENTALThis group will begin to receive the intervention immediately upon entering the study. Thinking in Speech is a novel cognitive therapy that helps children with autism independently cope with everyday events that cause stress, by developing their ability to use inner speech. Participants will complete two sessions per week for eight week, for a total of sixteen sessions. Sessions will be conducted by speech-language pathologists who are trained in Thinking in Speech. Sessions will be conducted via a secure Zoom platform.
Waitlist Assignment to Intervention Group
EXPERIMENTALThe Waitlist group will begin to receive the intervention 10 weeks after entering the study. Thinking in Speech is a novel cognitive therapy that helps children with autism independently cope with everyday events that cause stress, by developing their ability to use inner speech. Participants will complete two sessions per week for eight week, for a total of sixteen sessions. Sessions will be conducted by speech-language pathologists who are trained in Thinking in Speech. Sessions will be conducted via a secure Zoom platform.
Interventions
Thinking in Speech is a therapy to help children with autism learn to cope with daily stressors and improve their communication.
Eligibility Criteria
You may qualify if:
- Verbal language ability as reported by the caregiver
- Ages 7-11
- Prior autism or related neurocognitive diagnosis
- Child proficient in English
- Caregiver proficient in English
- Residing in Pennsylvania
- Access to internet at home
You may not qualify if:
- History of major child mental illness (e.g., bipolar, schizophrenia, psychosis)
- Child visual and/or hearing impairment that interferes with his/her ability to participate in therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara Baumann, PhD
University of Pittsburgh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Instructor in Psychiatry
Study Record Dates
First Submitted
February 15, 2022
First Posted
February 25, 2022
Study Start
May 12, 2021
Primary Completion
August 10, 2022
Study Completion
August 10, 2022
Last Updated
October 3, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share